Clinical Trial Update: Apatinib as First -Line Treatment for Advanced Esophagus Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase 2 trial of apatinib as first-line therapy for advanced esophageal cancer with the study status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Affiliated Hospital of North Sichuan Medical College | Conditions: Advanced Esophagus Cancer | Phase 2 | Status: UNKNOWN